Results of imatinib mesylate therapy in chronic myelogenous leukaemia with variant Philadelphia chromosome (Q44826305)

6 December 2017

title

Results of imatinib mesylate therapy in chronic myelogenous leukaemia with variant Philadelphia chromosome (English)

1 reference

6 December 2017

1 reference

1 reference

2

Hagop Kantarjian

1 reference

6 December 2017

9

Alessandra Ferrajoli

1 reference

6 December 2017

7

Srdan Verstovsek

1 reference

6 December 2017

4

Susan O'Brien

1 reference

6 December 2017

13

Mary B Rios

1 reference

6 December 2017

5

Francis Giles

1 reference

6 December 2017

Guillermo Garcia-Manero

6

object named as

Guillermo Garcia-Manero

1 reference

6 December 2017

15

Jorge E Cortes

1 reference

6 December 2017

3

Moshe Talpaz

1 reference

6 December 2017

14

Armand B Glassman

1 reference

6 December 2017

10

Kimberly Hayes

1 reference

6 December 2017

Maha M T El-Zimaity

1

1 reference

6 December 2017

Deborah Thomas

8

1 reference

6 December 2017

B Nebiyou Bekele

11

1 reference

6 December 2017

Xian Zhou

12

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

British Journal of Haematology

6 December 2017

published in

1 reference

6 December 2017

volume

125

1 reference

6 December 2017

issue

2

1 reference

6 December 2017

page(s)

187-195

1 reference

The incidence, type, and subsequent evolution of 14 variant Ph1 translocations in 180 South African patients with Ph1-positive chronic myeloid leukemia.

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04899.X

Subgroup of patients with Philadelphia-positive chronic myelogenous leukemia characterized by a deletion of 9q proximal to ABL gene: expression profiling, resistance to interferon therapy, and poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04899.X

Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04899.X

Effects of age on prognosis with imatinib mesylate therapy for patients with Philadelphia chromosome-positive chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04899.X

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04899.X

The biology of chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04899.X

Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04899.X

Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04899.X

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04899.X

Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04899.X

Heterogenic molecular basis for loss of ABL1-BCR transcription: deletions in der(9)t(9;22) and variants of standard t(9;22) in BCR-ABL1-positive chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04899.X

A Variant Chromosomal Translocation Found in a Series of 24 Patients with Philadelphia Positive Chronic Granulocytic Leukaemia*

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04899.X

Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04899.X

The impact of clonal evolution on response to imatinib mesylate (STI571) in accelerated phase CML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04899.X

Significance of non-standard Philadelphia chromosomes in chronic granulocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04899.X

21 January 2018

Chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04899.X

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04899.X

Masked Philadelphia chromosome caused by translocation (9;11;22).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04899.X

Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04899.X

Variant Philadelphia chromosome translocations in two patients with chronic myelogenous leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04899.X

Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04899.X

10.1111/J.1365-2141.2004.04899.X

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference